{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T10:05:55Z","timestamp":1771236355840,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC 82073810"],"award-info":[{"award-number":["NSFC 82073810"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013064","name":"Key Research and Development Program of Jiangxi Province","doi-asserted-by":"publisher","award":["BE2020696"],"award-info":[{"award-number":["BE2020696"]}],"id":[{"id":"10.13039\/501100013064","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.toxlet.2022.07.815","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T01:02:47Z","timestamp":1659142967000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Induction of CYP450 by illicit drugs: Studies using an in vitro 3D spheroidal model in comparison to animals"],"prefix":"10.1016","volume":"367","author":[{"given":"Shiqi","family":"Duan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lancheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2022.07.815_bib1","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1124\/dmd.112.044644","article-title":"Time-dependent inhibition and estimation of CYP3A clinical pharmacokinetic drug-drug interactions using plated human cell systems","volume":"40","author":"Albaugh","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2022.07.815_bib2","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/cpt.2141","article-title":"Metamizole is a moderate cytochrome P450 inducer via the constitutive androstane receptor and a weak inhibitor of CYP1A2","volume":"109","author":"Bachmann","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.toxlet.2022.07.815_bib3","article-title":"Could 3D models of cancer enhance drug screening","volume":"232","author":"Brancato","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.toxlet.2022.07.815_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.toxlet.2021.04.004","article-title":"Application of HepG2\/C3A liver spheroids as a model system for genotoxicity studies","volume":"345","author":"Coltman","year":"2021","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2022.07.815_bib5","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3390\/ijms18051085","article-title":"Assembly of hepatocyte spheroids using magnetic 3D cell culture for CYP450 inhibition\/induction","volume":"18","author":"Desai","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxlet.2022.07.815_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0378-5173(91)90408-G","article-title":"Localization of lipophilic molecules penetrating rat skin in vivo by quantitative autoradiography","volume":"74","author":"Fabin","year":"1991","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.toxlet.2022.07.815_bib7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.apsb.2016.07.012","article-title":"An update on the role of intestinal cytochrome P450 enzymes in drug disposition","volume":"6","author":"Fang","year":"2016","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.toxlet.2022.07.815_bib8","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0026-895X(24)12054-8","article-title":"Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity","volume":"10","author":"Faucette","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2022.07.815_bib9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00204-019-02427-4","article-title":"Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid","volume":"93","author":"Foster","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2022.07.815_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/18755453MTEyCOTgcx","article-title":"Metabolism and mechanism of human cytochrome P450 enzyme 1A2","volume":"22","author":"Guo","year":"2021","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.toxlet.2022.07.815_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41586-020-2099-x","article-title":"CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities","volume":"580","author":"Han","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.toxlet.2022.07.815_bib12","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0026-895X(24)12046-9","article-title":"CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants","volume":"10","author":"Hesse","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2022.07.815_bib13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/cpt.1599","article-title":"Complex DDI by fenebrutinib and the use of transporter endogenous biomarkers to elucidate the mechanism of DDI","volume":"107","author":"Jones","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.toxlet.2022.07.815_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bcp.2014.06.020","article-title":"Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo","volume":"91","author":"Kaspera","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxlet.2022.07.815_bib15","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100882","article-title":"Life-long impairment of glucose homeostasis upon prenatal exposure to psychostimulants","volume":"39","author":"Korchynska","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.toxlet.2022.07.815_bib16","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1039\/C7PY00559H","article-title":"Multicellular tumor spheroids: a relevant 3D model for the in vitro preclinical investigation of polymer nanomedicines","volume":"8","author":"Lazzari","year":"2017","journal-title":"Polym. Chem."},{"key":"10.1016\/j.toxlet.2022.07.815_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0009-2797(02)00051-0","article-title":"A review of the common properties of drugs with idiosyncratic hepatotoxicity and the \u201cmultiple determinant hypothesis\u201d for the manifestation of idiosyncratic drug toxicity","volume":"142","author":"Li","year":"2002","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.toxlet.2022.07.815_bib18","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/biot.200700228","article-title":"Recent advances in three-dimensional multicellular spheroid culture for biomedical research","volume":"3","author":"Lin","year":"2008","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.toxlet.2022.07.815_bib19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/00952990.2011.643997","article-title":"Drug interactions between common illicit drugs and prescription therapies","volume":"38","author":"Lindsey","year":"2012","journal-title":"Am. J. Drug Alcohol Abus."},{"key":"10.1016\/j.toxlet.2022.07.815_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.150840","article-title":"Application of triple co-cultured cell spheroid model for exploring hepatotoxicity and metabolic pathway of AFB1","volume":"807","author":"Ma","year":"2022","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.toxlet.2022.07.815_bib21","first-page":"1","article-title":"Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas-United States","volume":"66","author":"Mack","year":"2017","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.toxlet.2022.07.815_bib22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/01.ftd.0000211812.27558.6e","article-title":"Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine","volume":"28","author":"Maurer","year":"2006","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.toxlet.2022.07.815_bib23","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/bph.15370","article-title":"Characterization of cytochrome P450 (CYP) 2D6 drugs as substrates of human organic cation transporters and multidrug and toxin extrusion proteins","volume":"178","author":"Neul","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.toxlet.2022.07.815_bib24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ecoenv.2016.05.022","article-title":"Genotoxic effects induced by the exposure to an environmental mixture of illicit drugs to the zebra mussel","volume":"132","author":"Parolini","year":"2016","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.toxlet.2022.07.815_bib25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/JCP.0000000000001089","article-title":"The potential for pharmacokinetic interactions between cannabis products and conventional medications","volume":"39","author":"Qian","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.toxlet.2022.07.815_bib26","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1039\/D0BM02107E","article-title":"Establishment of a 3D model of tumor-driven angiogenesis to study the effects of anti-angiogenic drugs on pericyte recruitment","volume":"9","author":"Qiu","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.toxlet.2022.07.815_bib27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/toxsci\/kfx122","article-title":"Three-dimensional (3D) hepaRG spheroid model with physiologically relevant xenobiotic metabolism competence and hepatocyte functionality for liver toxicity screening","volume":"159","author":"Ramaiahgari","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2022.07.815_bib28","doi-asserted-by":"crossref","first-page":"806","DOI":"10.2174\/1389201018666171122124401","article-title":"In vitro characterization of NPS metabolites produced by human liver microsomes and the hepaRG cell line using liquid chromatographyhigh resolution mass spectrometry (LC-HRMS) analysis: application to furanyl fentanyl","volume":"18","author":"Richeval","year":"2017","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.toxlet.2022.07.815_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bcp.2018.08.026","article-title":"Delta9-tetrahydrocannabinol modulates the proteasome system in the brain","volume":"157","author":"Salgado-Mendiald\u00faa","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxlet.2022.07.815_bib30","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1007\/s00204-019-02576-6","article-title":"Development of in vitro 3D cell model from hepatocellular carcinoma (HepG2) cell line and its application for genotoxicity testing","volume":"93","author":"Stampar","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2022.07.815_bib31","article-title":"Illict drug use and academia in North Kosovo: prevalence, patterns, predictors and health-related quality of life","volume":"13","author":"Tatjana","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.toxlet.2022.07.815_bib32","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.dmpk.2015.10.001","article-title":"CYP1A1 and CYP1A2 expression levels are differentially regulated in three-dimensional spheroids of liver cancer cells compared to two-dimensional monolayer cultures","volume":"30","author":"Terashima","year":"2015","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.toxlet.2022.07.815_bib33","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/sj.tpj.6500330","article-title":"Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19","volume":"5","author":"Timm","year":"2005","journal-title":"Pharmacogenom. J."},{"key":"10.1016\/j.toxlet.2022.07.815_bib34","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1016\/j.xphs.2018.08.025","article-title":"Methadone metabolism and drug-drug interactions: in vitro and in vivo literature review","volume":"107","author":"Volpe","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.toxlet.2022.07.815_bib35","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1096\/fj.201601375R","article-title":"Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics","volume":"31","author":"Vorrink","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.toxlet.2022.07.815_bib36","doi-asserted-by":"crossref","first-page":"19103","DOI":"10.1038\/srep19103","article-title":"3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained","volume":"6","author":"Zanoni","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427422009705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427422009705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T05:26:57Z","timestamp":1759901217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427422009705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":36,"alternative-id":["S0378427422009705"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2022.07.815","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of CYP450 by illicit drugs: Studies using an in vitro 3D spheroidal model in comparison to animals","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2022.07.815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}